Find a Tender
complete
Official procurement procedure
Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial
Antihaemorrhagics
Cartons
Clinical products
+6 more
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: London School of Hygiene & Tropical Medicine: "Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | London School of Hygiene & Tropical Medicine | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: London School of Hygiene & Tropical Medicine
Market Analytics
Derived from OCDS awards & bid statistics
Published history for London School of Hygiene & Tropical Medicine. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
2.6Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 26 active published awards; 22 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityLondon School of Hygiene & Tropical Medicine | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published21 Aug 2023, 15:21 BST | Last source update21 Aug 2023, 15:21 BST | Recurring procurementNot published |
ClassificationAntihaemorrhagics, Cartons, Clinical products, Glass ampoules, Medical needles, Medicinal products for the blood and blood-forming organs, Packaging and related services, Pharmaceutical products, Syringes | ||
Delivery area | ||
OCIDocds-h6vhtk-02f911 | ||
What is being bought
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023.
Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution).
Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.
What changed
From the official release history
- tender value changed
21 Aug 2023, 15:21 BST - Status changed to complete
21 Aug 2023, 15:21 BST - Official notice release published
21 Aug 2023, 15:21 BST - Submission deadline changed to published date
21 Aug 2023, 15:21 BST - Published value updated to £975,000
22 Nov 2021, 18:10 GMT - Status changed to active
22 Nov 2021, 18:10 GMT - Official notice release published
22 Nov 2021, 18:10 GMT - Submission deadline changed to 5 Jan 2022, 13:00 GMT
22 Nov 2021, 18:10 GMT - Buyer information updated
22 Nov 2021, 18:10 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedManufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023. A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births. Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution). Treatment Kit Boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
21 Aug 2023, 15:21 BST - Award active
Not published · Not published - Contract active
Signed 10 Aug 2023, 00:00 BST · £1,066,444
Commercial outcome and competition
Awards Sharp Clinical Services (UK) Ltd Not published · Not published · active |
Contracts Investigational Medicinial Product (IMP) & Placebo Manufacture - IM Woman Trial £1,066,444 · signed 10 Aug 2023, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) electronicBids: 1 (lot 1) |
Buyer and organisations in this procedure
London School of Hygiene & Tropical Medicine
Contracting authority GB-FTS-33357Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published